No evidence of prolonged enterovirus excretion in HIV-seropositive patients

Tropical Medicine and International Health

Volumn 10, Issue 8, 2005, Pages 743-747

  Gouandjika Vasilache, Ionela ^a   Akoua Koffi, Chantal ^b   Begaud, Evelyne ^a   Dosseh, Annick ^c   Delpeyroux, Francis ^d  

^a INSTITUT PASTEUR DE BANGUI   (Central African Republic)

^b INSTITUT PASTEUR DE CÔTE D'IVOIRE   (Côte d’Ivoire)

^c INSTITUT PASTEUR DE DAKAR   (Senegal)

^d INSTITUT PASTEUR   (France)

Author keywords

Adults; Excretion; Human immunodeficiency virus; Oral poliovirus vaccine

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

HUMAN IMMUNODEFICIENCY VIRUS;

ADULT; ARTICLE; BLOOD SAMPLING; CENTRAL AFRICA; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROVIRUS; FECES ANALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNIZATION; MALE; PREVALENCE; RISK FACTOR; VIRUS EXCRETION; VIRUS ISOLATION; VIRUS STRAIN;

ADULT; CHILD; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; FAMILY HEALTH; FECES; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

ENTEROVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; POLIOVIRUS;

EID: 23244455386     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2005.01454.x     Document Type: Article

References (22)

1. Bellmunt A, May G, Zell R, Pring-Akerblom P, Verhagen W & Heim A (1999) Evolution of poliovirus type 1 during 5.5 years of prolonged enteral replication in an immunodeficient patient. Virology 265, 178-184.
2. Chitsike I & van Furth R (1999) Paralytic poliomyelitis associated with live oral poliomyelitis vaccine in a child with HIV infection in Zimbabwe: case report. British Medical Journal 318, 841-843.
3. Dean AG, Dean JA, Coulombier D et al. (1996) Epi Info, Version 6.04a, a Word Processing Data Base, and Statistics Program for Public Health on IBM-compatible Microcomputers. Centers for Disease Control and Prevention, Atlanta, GA.
4. Fox JP, Gelfand HM, LeBlanc DR, Potash L, Clemmer DI & LaPenta D (1961) The spread of vaccine strains of poliovirus in the household and the community in southern Louisiana. In: International Poliomyelitis Congress. Lippincott, Philadelphia, pp. 368-383.
5. Georgescu MM, Delpeyroux F, Tardy-Panit M et al. (1994) High diversity of poliovirus strains isolated from the central nervous system of patients with vaccine-associated paralytic poliomyelitis. Journal of Virology 68, 8089-8101.
6. Giorgio J (1992). CD4 counts as surrogate markers for AIDS. In: Immunodeficiency in HIV Infection and AIDS (ed. Karger S), Basel, Switzerland, pp. 13.
7. Gounadjika I, Rakoto Andrianarivelo M, Akoua-Koffi C, Zeller H, Ehouman A & Morvan JM (2000) Circulation des Poliovirus en zone d'endemie chez les enfants vaccinés par le vaccin polio oral. Bulletin de la Société de Pathologie Exotique 93, 198-201.
8. Grohmann GS, Glass IR, Pereira HG et al. (1993) Enteric viruses and diarrhea in HIV-infected patients. New England Journal of Medicine 329, 14-20.
9. Hara M, Saito Y, Komatsu T et al. (1981) Antigenic analysis of polioviruses isolated from a child with agammaglobinemia and paralytic poliomyelitis after Sabin vaccine administration. Microbiology and Immunology 25, 905-913.
10. Kona R, Miyamura K, Yamazaki S et al. (1981) Seroepidemiologic studies of acute hemorragic conjunctivitis virus (enterovirus 70) in West Africa. II. Studies with human sera collected in West African countries other then Ghana. American Journal of Epidemiology 114, 274-283.
11. Lipskaya GY, Muzychenko AR, Kutikova OK et al. (1991) Frequent isolation of intertypic poliovirus recombinants with serotype 2 specificity from vaccine-associated polio cases. Journal of Medical Virology 35, 290-296.
12. Martin J, Dunn G, Hull R, Varsha P & Minor PD (2000) Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. Journal of Virology 7, 3001-3010.
13. McKinney RE Jr, Katz SL & Wilfert CM (1987) Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Reviews of Infectious Diseases 9, 334-356.
14. Menard D, Mandeng MJ, Bem-Tothy M, Kassa-Kelembho E, Grésenguet G & Talarmin A (2003) Immunohematological reference ranges for adults from Central African Republic. Clinical and Diagnostic Laboratory Immunology 10, 443-445.
15. Misbah SA, Lawrence PA, Kurtz JB & Chapel HM (1991) Prolonged faecal excretion of poliovirus in a nurse with common variable hypogammaglobulinemia. Postgraduate Medical Journal 67, 301-303.
16. Nedelcu I, Dobrecsu A, Strebel PM & Sutter W (1994) Vaccine-associated paralytic poliomyelitis and HIV infection. Lancet 343, 51-52.
17. Sutter RW, Tangerman RH, Aylward RB & Cochi SL (2001) Poliomyelitis eradication: progress, challenges for the end game, and preparation for the post-eradication era. Infectious Disease Clinics of North America 15, 41-64.
18. Vermon (1990) Paralytic poliomyelitis and HIV infection in Kinshasa, Zaire. Sixth International Conference on AIDS, San Francisco, CA, USA, 20-24 June 1990.
19. Wood D & Hull B (1999) L20B cells simplify culture of poliovirus from clinical samples. Journal of Virology 58, 188-192.
20. World Health Organization (1993) The Initiative for Global Eradication of Poliomyelitis: A Guide Field for Clinicians. (WHO/EPI/POLIO/93-2) WHO, Geneva.
21. World Health Organization (1997) Manual for the Virological Investigation of Polio. (WHO/EPI/GEN/97.01) WHO, Geneva.
22. Zaouti T & Klein JD (1998) Enterovirus infections. Pediatrics in Review 19, 183-191.